Figure 2

Kaplan-Meier plot of survival durations in gastric cancer patients with different Sirt7 expression.
(A) Overall survival and (B) disease-free survival duration are poor in gastric cancer patients with higher Sirt7 expression. (C) Overall survival and (D) disease-free survival duration are poor in intestinal gastric cancer patients with higher Sirt7 expression. (E) Overall survival and (F) disease-free survival duration are poor in diffuse gastric cancer patients with higher Sirt7 expression.